July 29, 2026
View Full PaperCardiovascular-Kidney-Metabolic Syndrome: Population and Policy Implications: 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome
Key Points
- To address the implications of cardiovascular-kidney-metabolic syndrome on population health and provide comprehensive guidelines.
- Development of updated clinical guidelines by AHA, ACC, ADA, and ASN.
- Assessment of current evidence for prevention and management strategies.
- Integration of policy recommendations for healthcare systems.
- Identified key risk factors for cardiovascular-kidney-metabolic syndrome in diverse populations.
- Provided actionable strategies for healthcare providers to improve patient outcomes.
- Highlighted the importance of community-based interventions in managing disease prevalence.
Expert Takes5 quotes
1/5
“This guideline calls for earlier screening and care, focusing on prevention and coordinated action to reduce the risk of cardiovascular disease before serious complications develop or a major cardiac event occurs.”
Dr. Chiadi E. Ndumele, Chair of the guideline writing committeeJohns Hopkins School of Medicinegemini_groundedView source